Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |